{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:38:58Z","timestamp":1790163538387,"version":"4.1.0"},"reference-count":33,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.3892\/ol.2016.5056","type":"journal-article","created":{"date-parts":[[2016,8,29]],"date-time":"2016-08-29T07:44:38Z","timestamp":1472456678000},"page":"3234-3240","source":"Crossref","is-referenced-by-count":15,"title":["mTOR downstream effectors, 4EBP1 and eIF4E, are overexpressed and associated with HPV status in precancerous lesions and carcinomas of the uterine cervix"],"prefix":"10.3892","volume":"12","author":[{"given":"Aristidis","family":"Asimomytis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Karanikou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Rodolakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Vaiopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paraskevi","family":"Tsetsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Creatsas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodoros","family":"Stefos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aristidis","family":"Antsaklis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstratios","family":"Patsouris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George Z.","family":"Rassidakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2016,8,29]]},"reference":[{"issue":"Suppl 5","key":"key20180108111134_b1-ol-0-0-5056","doi-asserted-by":"crossref","first-page":"F12","DOI":"10.1016\/j.vaccine.2012.07.055","article-title":"Global burden of human papillomavirus and related diseases","volume":"30","author":"Forman","year":"2012","journal-title":"Vaccine"},{"key":"key20180108111134_b2-ol-0-0-5056","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"Int J Cancer"},{"key":"key20180108111134_b3-ol-0-0-5056","first-page":"168","volume-title":"IARC Handbook of Cancer Prevention","author":"World Health Organization","year":"2005","edition":"1st"},{"issue":"Suppl 3","key":"key20180108111134_b4-ol-0-0-5056","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vaccine.2006.05.115","article-title":"Chapter 1: HPV in the etiology of human cancer","volume":"24","author":"Mu\u00f1oz","year":"2006","journal-title":"Vaccine"},{"key":"key20180108111134_b5-ol-0-0-5056","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"key20180108111134_b6-ol-0-0-5056","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.16.1.1-17.2003","article-title":"Human papillomavirus and cervical cancer","volume":"16","author":"Burd","year":"2003","journal-title":"Clin Microbiol Rev"},{"key":"key20180108111134_b7-ol-0-0-5056","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/jcp.51.2.96","article-title":"Aetiology, pathogenesis, and pathology of cervical neoplasia","volume":"51","author":"Arends","year":"1998","journal-title":"J Clin Pathol"},{"key":"key20180108111134_b8-ol-0-0-5056","first-page":"131","article-title":"A modified terminology for cervical intraepithelial neoplasia","volume":"75","author":"Richart","year":"1990","journal-title":"Obstet Gynecol"},{"key":"key20180108111134_b9-ol-0-0-5056","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1101\/gad.1212704","article-title":"Upstream and downstream of mTOR","volume":"18","author":"Hay","year":"2004","journal-title":"Genes Dev"},{"key":"key20180108111134_b10-ol-0-0-5056","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1128\/JVI.02319-12","article-title":"Cellular entry of human papillomavirus type 16 involves activation of the phosphatidylinositol 3-kinase\/Akt\/mTOR pathway and inhibition of autophagy","volume":"87","author":"Surviladze","year":"2013","journal-title":"J Virol"},{"key":"key20180108111134_b11-ol-0-0-5056","doi-asserted-by":"crossref","first-page":"7207","DOI":"10.1158\/1078-0432.CCR-09-1249","article-title":"Targeted inhibition of mammalian target of rapamycin signaling inhibits tumorigenesis of colorectal cancer","volume":"15","author":"Gulhati","year":"2009","journal-title":"Clin Cancer Res"},{"key":"key20180108111134_b12-ol-0-0-5056","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/lary.20917","article-title":"Teasing out the best molecular marker in the AKT\/mTOR pathway in head and neck squamous cell cancer patients","volume":"120","author":"Clark","year":"2010","journal-title":"Laryngoscope"},{"key":"key20180108111134_b13-ol-0-0-5056","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1158\/1078-0432.CCR-11-2824","article-title":"mTOR as a molecular target in HPV-associated oral and cervical squamous carcinomas","volume":"18","author":"Molinolo","year":"2012","journal-title":"Clin Cancer Res"},{"key":"key20180108111134_b14-ol-0-0-5056","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1038\/sj.bjc.6605044","article-title":"Combined analysis of eIF4E and 4E-binding protein expression predicts breast cancer survival and estimates eIF4E activity","volume":"100","author":"Coleman","year":"2009","journal-title":"Br J Cancer"},{"key":"key20180108111134_b15-ol-0-0-5056","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ygyno.2010.12.364","article-title":"Activation of mTOR signaling pathway associated with adverse prognostic factors of epithelial ovarian cancer","volume":"121","author":"No","year":"2011","journal-title":"Gynecol Oncol"},{"key":"key20180108111134_b16-ol-0-0-5056","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1002\/cncr.24506","article-title":"Expression of eukaryotic initiation factor 4E predicts clinical outcome in patients with mantle cell lymphoma treated with hyper-CVAD and rituximab, alternating with rituximab, high-dose methotrexate, and cytarabine","volume":"115","author":"Inamdar","year":"2009","journal-title":"Cancer"},{"key":"key20180108111134_b17-ol-0-0-5056","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.surg.2011.09.022","article-title":"Activation of mTOR signaling in medullary and aggressive papillary thyroid carcinomas","volume":"150","author":"Kouvaraki","year":"2011","journal-title":"Surgery"},{"key":"key20180108111134_b18-ol-0-0-5056","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1128\/JCM.42.7.3176-3184.2004","article-title":"Detection and typing of human papillomavirus by e6 nested multiplex PCR","volume":"42","author":"Sotlar","year":"2004","journal-title":"J Clin Microbiol"},{"key":"key20180108111134_b19-ol-0-0-5056","doi-asserted-by":"crossref","first-page":"6589","DOI":"10.1158\/0008-5472.CAN-05-3018","article-title":"Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma","volume":"66","author":"Vega","year":"2006","journal-title":"Cancer Res"},{"key":"key20180108111134_b20-ol-0-0-5056","doi-asserted-by":"crossref","first-page":"9398","DOI":"10.1128\/JVI.00974-10","article-title":"The human papillomavirus type 16 E6 oncoprotein activates mTORC1 signaling and increases protein synthesis","volume":"84","author":"Spangle","year":"2010","journal-title":"J Virol"},{"key":"key20180108111134_b21-ol-0-0-5056","first-page":"249","article-title":"Morphoproteomic evidence of constitutively activated and overexpressed mTOR pathway in cervical squamous carcinoma and high grade squamous intraepithelial lesions","volume":"2","author":"Feng","year":"2009","journal-title":"Int J Clin Exp Pathol"},{"key":"key20180108111134_b22-ol-0-0-5056","first-page":"57","article-title":"Predictive and prognostic role of activated mammalian target of rapamycin in cervical cancer treated with cisplatin-based neoadjuvant chemotherapy","volume":"16","author":"Faried","year":"2006","journal-title":"Oncol Rep"},{"key":"key20180108111134_b23-ol-0-0-5056","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/01.pai.0000170625.98446.3e","article-title":"eIF4E as a marker for cervical neoplasia","volume":"13","author":"Matthews-Greer","year":"2005","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"key20180108111134_b24-ol-0-0-5056","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrm3025","article-title":"mTOR: From growth signal integration to cancer, diabetes and ageing","volume":"12","author":"Zoncu","year":"2011","journal-title":"Nat Rev Mol Cell Biol"},{"key":"key20180108111134_b25-ol-0-0-5056","doi-asserted-by":"crossref","first-page":"10314","DOI":"10.1073\/pnas.171076798","article-title":"Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP\/mTOR","volume":"98","author":"Neshat","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108111134_b26-ol-0-0-5056","doi-asserted-by":"crossref","first-page":"10320","DOI":"10.1073\/pnas.171060098","article-title":"An inhibitor of mTOR reduces neoplasia and normalizes p70\/S6 kinase activity in Pten+\/-mice","volume":"98","author":"Podsypanina","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3-4","key":"key20180108111134_b27-ol-0-0-5056","first-page":"e1","article-title":"Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors","volume":"36","author":"Ronco","year":"2012","journal-title":"Epidemiol Prev"},{"issue":"Suppl 5","key":"key20180108111134_b28-ol-0-0-5056","doi-asserted-by":"crossref","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","article-title":"Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer","volume":"30","author":"Arbyn","year":"2012","journal-title":"Vaccine"},{"key":"key20180108111134_b29-ol-0-0-5056","doi-asserted-by":"crossref","first-page":"7079","DOI":"10.1128\/JVI.02380-05","article-title":"Deregulation of eIF4E: 4E-BP1 in differentiated human papillomavirus-containing cells leads to high levels of expression of the E7 oncoprotein","volume":"80","author":"Oh","year":"2006","journal-title":"J Virol"},{"key":"key20180108111134_b30-ol-0-0-5056","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.febslet.2013.01.042","article-title":"HPV E6 induces eIF4E transcription to promote the proliferation and migration of cervical cancer","volume":"587","author":"Wang","year":"2013","journal-title":"FEBS Lett"},{"key":"key20180108111134_b31-ol-0-0-5056","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.oraloncology.2012.04.013","article-title":"Difference in expression of EGFR, pAkt, and PTEN between oropharyngeal and oral cavity squamous cell carcinoma","volume":"48","author":"Won","year":"2012","journal-title":"Oral Oncol"},{"key":"key20180108111134_b32-ol-0-0-5056","first-page":"1951","article-title":"Targeting mTOR and AREG with everolimus, sunitinib and sorafenib in HPV-positive and-negative SCC","volume":"35","author":"Aderhold","year":"2015","journal-title":"Anticancer Res"},{"key":"key20180108111134_b33-ol-0-0-5056","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ygyno.2013.05.008","article-title":"Phase II study of temsirolimus (CCI-779) in women with recurrent, unresectable, locally advanced or metastatic carcinoma of the cervix. A trial of the NCIC Clinical Trials Group (NCIC CTG IND 199)","volume":"130","author":"Tinker","year":"2013","journal-title":"Gynecol Oncol"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2016.5056\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T16:13:07Z","timestamp":1601050387000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2016.5056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,29]]},"references-count":33,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,8,29]]},"published-print":{"date-parts":[[2016,11]]}},"alternative-id":["10.3892\/ol.2016.5056"],"URL":"https:\/\/doi.org\/10.3892\/ol.2016.5056","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,29]]}}}